Patents by Inventor Sooin CHAE

Sooin CHAE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Indole carboxamide derivative and pharmaceutical composition containing same
    Patent number: 12465588
    Abstract: Indole carboxamide compounds of Formula (II) or pharmaceutically acceptable salt thereof have activity of inhibiting production of prostaglandin E2 (PGE2) through inhibition of microsomal prostaglandin E2 synthase-1 (mPGES-1). The indole carboxamide compounds and salts can be effectively used in treating or preventing inflammation, arthritis, high fever, pain, cancer, stroke or brain diseases such as Alzheimer's disease. A pharmaceutical composition contains the indole carboxamide compound as an active ingredient.
    Type: Grant
    Filed: August 26, 2020
    Date of Patent: November 11, 2025
    Assignee: KUKJE PHARMA CO., LTD.
    Inventors: Younghoon Kim, Juhee Lee, Changmin Park, Sehoan Kim, Jungmin Seo, Shinyoung Lee, Sooin Chae, Younggwan Kim
  • INDOLE CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
    Publication number: 20230000821
    Abstract: Indole carboxamide compounds of Formula (II) or pharmaceutically acceptable salt thereof have activity of inhibiting production of prostaglandin E2 (PGE2) through inhibition of microsomal prostaglandin E2 synthase-1 (mPGES-1). The indole carboxamide compounds and salts can be effectively used in treating or preventing inflammation, arthritis, high fever, pain, cancer, stroke or brain diseases such as Alzheimer's disease. A pharmaceutical composition contains the indole carboxamide compound as an active ingredient.
    Type: Application
    Filed: August 26, 2020
    Publication date: January 5, 2023
    Applicant: KUKJE PHARMA CO., LTD.
    Inventors: Younghoon KIM, Juhee LEE, Changmin PARK, Sehoan KIM, Jungmin SEO, Shinyoung LEE, Sooin CHAE, Younggwan KIM